Momentum Events: Strategy Summit on Paragraph IV Litigation


Momentums Strategy Summit on Paragraph IV Litigation will include: carve-outs, estoppel, restrictions on venue, and ANDA and Biosimilars litigation. Brian’s presentation, “Assessing IP Rights Related to Biosimilars, the BPCIA, and Associated IP Litigation” will explore:

  • Examining the difference between “Hatch-Waxman” (and the “BPCIA” (Biologics Price Competition and Innovation Act)
  • Analyzing the participating in the “patent dance” and the disclosure of information found in the aBLA
  • Exploring how participation in the dance affects the rights of a company to “seek a declaration of infringement, validity, or enforceability of any patent that claims the biological product or a use of the biological product”

Learn about the event and register here.

Pour aller plus loin

McDermott Event / April 28-29, 2022

Life Sciences Dealmakers Symposium

San Francisco, CA / McDermott Event / January 10-11, 2022

2022 J.P. Morgan Healthcare Conference

Virtual Event / Speaking Engagements / December 1-3, 2021

EIT Health Catapult Awards

Webinaire / Speaking Engagements / 23 novembre 2021

Santé & Cybersecurité : Réglementations et Bonnes Pratiques Post-COVID 19

Virtual Conference / Speaking Engagements / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity